Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Shares Outstanding (Weighted Average) (2021 - 2025)

Coeptis Therapeutics Holdings has reported Shares Outstanding (Weighted Average) over the past 5 years, most recently at $570105.0 for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $570105.0 for Q4 2025, down 70.38% from a year ago — trailing twelve months through Dec 2025 was $570105.0 (down 70.38% YoY), and the annual figure for FY2025 was $570105.0, down 70.38%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $570105.0 at Coeptis Therapeutics Holdings, down from $695015.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for COEPW hit a ceiling of $39.8 million in Q3 2024 and a floor of $250000.0 in Q3 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $1.9 million (2021), compared with a mean of $9.2 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 7790.9% in 2024 and later plummeted 98.25% in 2025.
  • Coeptis Therapeutics Holdings' Shares Outstanding (Weighted Average) stood at $10.9 million in 2021, then skyrocketed by 30.98% to $14.3 million in 2022, then crashed by 95.37% to $661601.0 in 2023, then soared by 190.91% to $1.9 million in 2024, then plummeted by 70.38% to $570105.0 in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $570105.0 (Q4 2025), $695015.0 (Q3 2025), and $770105.0 (Q2 2025) per Business Quant data.